HPV vaccination and anal (vs. oral) HPV infection; single-tablet E/C/F/TDF vs. HIV-2; an HIV-positive infant’s “founder” virus; male circumcision and antiretroviral scale-up in Kenya.
Primary care providers are well positioned to screen for and prescribe PrEP, according to a recent research review -- but many PCPs feel ill equipped to prescribe what they perceive as an HIV medication.
Prevalence of non-AIDS comorbidities prior to HIV diagnosis; wealth and HIV treatment access amidst universal health care; the uncertain benefits of food supplementation; the results of universal hepatitis C treatment access.
Non-HIV components of care may be neglected during health care visits because the focus is on HIV, said Steven C. Johnson, M.D., in a recent webinar.
Substance use rates among people with HIV; the continuing risk of PML; tenofovir gel efficacy and menopause; the cumulative cost of the global fight against HIV.
The effect of vitamin D levels on CD4 count during HIV treatment; helping black men who have sex with men utilize PrEP; HIV and aortic stiffness; Legionnaires’ disease severity among people with HIV.
Tobacco use and HIV discrimination; enhancing viral suppression after prison with naltrexone; asymptomatic myocardial impairment during acute HIV infection; undetectability and yellow fever vaccine efficacy.
Most people who could benefit from pre-exposure prophylaxis are not accessing it, the U.S. Centers for Disease Control and Prevention revealed at this year's Conference on Retroviruses and Opportunistic Infections.
HIV in plasma vs. rectal mucosa; engagement in care while on PrEP; depression and outcomes among women with HIV; dolutegravir resistance in the wake of monotherapy.